Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.51131 | 20 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.49101 | 21 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.48229 | 20 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.5102 | 24 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.44487 | 21 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.5663 | 21 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.65216 | 27 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.83643 | 37 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.46473 | 21 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.47115 | 20 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.46943 | 20 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.46396 | 21 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.5091 | 22 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.49107 | 21 |